A Study in Healthy Adult Male & Female Participants to Assess the Amount of the Study Medicine (SAR443820) Absorbed by the Body, When Given Orally in Fasted Condition as a Tablet Versus as a Capsule (Part 1) and When Given Orally as a Tablet in Fasted Condition Versus as a Tablet After Food (Part 2)

Exclusion Criteria

• •Any history or presence of clinically relevant cardiovascular, pulmonary, gastrointestinal, hepatic, renal, metabolic, hematological, neurological, osteomuscular, articular, psychiatric, systemic, ocular, or infectious disease, or signs of acute illness
• •Any medication (including St John's Wort) within 14 days before inclusion or within 5 times the elimination half-life or pharmacodynamic half-life of the medication, with the exception of hormonal contraception or menopausal hormone replacement therapy; any non-live Covid-19 vaccine within the last 2 weeks before randomization, any live attenuated vaccine within the last 28 days before randomization and any other non-vaccine biological drugs given within 4 months before randomization
• •Positive result for hepatitis B, C or human immunodeficiency virus (HIV)
• •Positive result on urine drug screen
• •Positive urine alcohol test
• •Positive severe acute respiratory syndrom coronavirus 2 (SARS-CoV-2) test
• •Any consumption of citrus fruits (grapefruit, orange, etc) or their juices within 5 days before inclusion
• •The above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.